Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
L'Oreal (LRLCY US)
Watchlist
8
Analysis
Consumer Staples
•
France
L'Oreal manufactures cosmetics. The Company offers mascara, lip gloss, foundation, eyeshadow, primer, nail polish, lipstick, face powder, blusher, and concealer, as well as skin, hair, and body care products. L'Oreal serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Giant Biogene
•
23 Nov 2023 08:22
2024 High Conviction - Giant Biogene - Growth Rate Keeps Moving Higher
Giant Biogene was listed in Hong Kong IPO in 2022. It has done well since and is now trading 45% above its IPO price, but its still cheap.
Sumeet Singh
Follow
654 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 Mar 2025 15:56
•
Broker
Consumer Staples - Mao Geping & Giant Bio Surged, Marubi & Jahwa Had a Strong Start
Feb cosmetics sales data shows that domestic brands were focusing on Douyin, with a particularly strong growth in skincare segment.
CMB International
Follow
194 Views
Share
bullish
•
L'Occitane
•
17 May 2024 04:23
L'Occitane (973.HK) Privatization - The Offer Price Is Good Enough
The Offeror has received valid expressions of interest from Minority Shareholders holding, in aggregate, not less than 10% of Disinterested Shares....
Xinyao (Criss) Wang
Follow
873 Views
Share
bullish
•
Thematic (Sector/Industry)
•
27 Feb 2024 01:22
•
Syndicated
Maverick Charts & Markets - February 2024 Edition #15
note how the -4.63% growth last year was a rate that meant it was the fastest pace of money supply compression since Jan 1933 ... let that sink in!
Maverick Equity Research
Follow
265 Views
Share
bearish
•
iShares MSCI ACWI ETF
•
31 Mar 2023 19:39
Shift To Defensives as $ACWI Makes Push for $93; Remain Overweight Europe; Opptys in China/HK, Japan
$ACWI, $ACWX, $EFA, and $EEM all reversing topside their 2-month downtrends. Despite this bullish short-term development, we still expect $93 to...
Vermilion Research
Follow
550 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x